Effect of oral zinc intake on delta-aminolaevulinic acid dehydratase in red blood cells.
Earlier results regarding the in vitro and in vivo effects of zinc on delta-aminolaevulinic acid dehydratase (ALAD) activity in red blood cells were confirmed in healthy human subjects after oral intake of zinc for 12 weeks. In one group of seven healthy adults, oral intake of zinc for 12 weeks. In one group of seven healthy adults, oral intake of zinc, as the sulphate salt (2.07 mmol zinc/day) for 6 weeks, resulted in a 44% increase in the activity of ALAD in erythrocytes. Plasma zinc levels also increased during the experimental period and reached a maximum of 29 mumol after 6 weeks and remained constant thereafter. In another group, the intake of zinc in a lower dose, (0.69 mmol zinc/day) for 12 weeks, showed a similar tendency, although the increase in the enzyme activity, as well as the plasma zinc levels, was relatively much less. The plasma copper levels decreased significantly in the second group after the zinc intake and reached a low value of 11 mumol at the end of the experimental period. The Cu:Zn ratio also decreased considerably towore valuable indicator of zinc status than plasma zinc levels alone.
D000284:Administration, Oral; D000328:Adult; D003300:Copper / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology*; D006801:Humans; D000623:Porphobilinogen Synthase / Q000097:blood*; D015032:Zinc / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*
D003300:Copper; D000623:Porphobilinogen Synthase; D015032:Zinc